HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adam Reich Selected Research

Infliximab (Remicade)

8/2022Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program "Treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in Poland.
1/2021Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature.
1/2021Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.
1/2021AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings.
12/2020The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adam Reich Research Topics

Disease

37Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023 - 01/2007
22Pruritus (Itching)
10/2023 - 01/2005
8Neoplasms (Cancer)
02/2024 - 12/2015
7Atopic Dermatitis (Atopic Eczema)
10/2023 - 11/2008
5Prurigo
05/2024 - 01/2020
5Body Weight (Weight, Body)
11/2023 - 01/2011
5Mycosis Fungoides
02/2017 - 11/2015
4Infections
10/2023 - 02/2006
4Inflammation (Inflammations)
10/2023 - 06/2020
4Eczema
03/2023 - 11/2008
4Skin Diseases (Skin Disease)
02/2017 - 04/2013
3Acne Vulgaris
10/2022 - 06/2019
3Cutaneous Lupus Erythematosus
10/2013 - 09/2006
2Actinic Keratosis
11/2023 - 06/2023
2Nausea
10/2023 - 09/2019
2COVID-19
10/2023 - 01/2021
2Headache (Headaches)
10/2023 - 01/2023
2Urticaria (Hives)
10/2023 - 12/2022
2Chronic Urticaria
10/2023 - 12/2022
2Pyoderma Gangrenosum
08/2023 - 01/2023
2Hidradenitis Suppurativa
01/2023 - 01/2022
2Melanoma (Melanoma, Malignant)
01/2022 - 06/2019
2Mental Disorders (Mental Disorder)
01/2022 - 12/2019
2Neoplasm Metastasis (Metastasis)
01/2018 - 12/2015
2Lichen Planus (Lichen Ruber Planus)
11/2015 - 01/2013
2Onychomycosis (Tinea Unguium)
07/2009 - 10/2006
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2024
1Osteoporosis
02/2024
1Psoriatic Arthritis
12/2023
1Basal Cell Carcinoma (Rodent Ulcer)
11/2023
1Nasopharyngitis
10/2023
1Pityriasis Rubra Pilaris
10/2023
1Alopecia Areata
03/2023
1Alopecia universalis
03/2023
1Vitiligo
01/2022
1Hyperhidrosis
01/2022

Drug/Important Bio-Agent (IBA)

6secukinumabIBA
10/2023 - 12/2020
6betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
09/2023 - 10/2021
6calcipotriene (calcipotriol)FDA LinkGeneric
09/2023 - 10/2021
5Immunoglobulin A (IgA)IBA
10/2023 - 01/2017
5Adalimumab (Humira)FDA Link
10/2023 - 02/2016
5Infliximab (Remicade)FDA Link
08/2022 - 12/2020
5AntipruriticsIBA
09/2019 - 01/2007
4ixekizumabIBA
12/2023 - 12/2018
4Ustekinumab (CNTO 1275)FDA Link
11/2023 - 12/2020
4Monoclonal AntibodiesIBA
10/2023 - 10/2013
4risankizumabIBA
10/2023 - 12/2020
4InterleukinsIBA
09/2023 - 01/2007
4Prostaglandins AIBA
09/2023 - 08/2017
4NeuropeptidesIBA
10/2021 - 01/2007
4LipidsIBA
01/2021 - 01/2005
3nemolizumabIBA
05/2024 - 01/2020
3EnzymesIBA
09/2023 - 02/2006
3SuspensionsIBA
09/2023 - 03/2022
3CytokinesIBA
09/2023 - 06/2004
3Substance PIBA
10/2021 - 01/2007
3Etanercept (Enbrel)FDA Link
01/2021 - 12/2018
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 11/2008
3EmollientsIBA
02/2020 - 06/2005
3EndocannabinoidsIBA
01/2016 - 01/2005
2Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2016
2Biosimilar PharmaceuticalsIBA
11/2023 - 08/2022
2apremilastIBA
10/2023 - 01/2016
2remibrutinibIBA
10/2023 - 12/2022
2Histamine Antagonists (Antihistamines)IBA
10/2023 - 10/2017
2Interleukin-23 (Interleukin 23)IBA
09/2023 - 01/2022
2Local Anti-Infective Agents (Antiseptics)IBA
01/2023 - 09/2005
2AerosolsIBA
06/2022 - 10/2021
2Calcitonin Gene-Related PeptideIBA
10/2021 - 05/2007
2Serotonin (5 Hydroxytryptamine)IBA
10/2021 - 01/2007
2Peptide Hydrolases (Proteases)FDA Link
10/2021 - 01/2007
2SteroidsIBA
08/2021 - 05/2021
2AcitretinFDA Link
01/2021 - 01/2021
2AntigensIBA
04/2020 - 01/2009
2Anti-Bacterial Agents (Antibiotics)IBA
03/2019 - 09/2005
2Opioid Receptors (Opioid Receptor)IBA
05/2017 - 01/2012
2CalciumIBA
11/2016 - 06/2004
2CannabinoidsIBA
01/2016 - 01/2005
2Opioid Analgesics (Opioids)IBA
01/2012 - 01/2007
2Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
05/2007 - 01/2007
2Neuropeptide YIBA
05/2007 - 01/2007
1Oxygen (Dioxygen)IBA
11/2023
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2023
1Photosensitizing Agents (Photosensitizers)IBA
11/2023
1LigandsIBA
10/2023
1Agammaglobulinaemia Tyrosine KinaseIBA
10/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2023
1upadacitinibIBA
03/2023
1Janus Kinase InhibitorsIBA
03/2023
1W 12IBA
11/2022
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2022
1Interleukin-12 (IL 12)IBA
01/2022

Therapy/Procedure

27Therapeutics
10/2023 - 01/2005
3Photochemotherapy (Photodynamic Therapy)
11/2023 - 06/2023
3Immunotherapy
01/2022 - 06/2019
2Contraindications
08/2022 - 01/2022
2Conservative Treatment
11/2016 - 02/2015
2Renal Dialysis (Hemodialysis)
01/2016 - 01/2005
1Subcutaneous Injections
10/2023
1Hematopoietic Stem Cell Transplantation
08/2023